- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
13 result(s) found for: Anesthetic agents.
Displaying page 1 of 1.
| EudraCT Number: 2019-001534-34 | Sponsor Protocol Number: 260319 | Start Date*: 2022-03-11 | |||||||||||
| Sponsor Name:Odense University Hospital | |||||||||||||
| Full Title: Propofol and thiopental for intravenous induction in neonates: a dose finding study | |||||||||||||
| Medical condition: Any condition requiring general anesthesia. | |||||||||||||
|
|||||||||||||
| Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-001850-83 | Sponsor Protocol Number: 2012/175/HP | Start Date*: 2013-08-02 | |||||||||||
| Sponsor Name:CHU- Hôpitaux de Rouen | |||||||||||||
| Full Title: Adaptation to neonatal life after an anesthetic protocol using remifentanil for general anesthesia for caesarean section in a context of prematurity - REAGI Protocol (Remifentanil for General Anes... | |||||||||||||
| Medical condition: pregnant woman older than 18 years with an indication for caesarean section under general anesthesia in a context of prematurity. | |||||||||||||
|
|||||||||||||
| Population Age: Preterm newborn infants, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-008193-31 | Sponsor Protocol Number: 2008/44 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Hopital Foch | |||||||||||||
| Full Title: Impact des facteurs chronologiques et démographiques sur les posologies per-opératoires des agents anesthésiques (Etude prospective multicentrique) | |||||||||||||
| Medical condition: general anesthesia | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-003737-19 | Sponsor Protocol Number: CHUB-ITF-sevo-propofol | Start Date*: 2023-01-10 |
| Sponsor Name:CHU Brugmann | ||
| Full Title: Influence of sevoflurane and propofol on maximum muscular strength, speed of contraction and relaxation, in humans: A pilot study. | ||
| Medical condition: Impact of anesthetic drugs on neuromuscular transmission | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-001496-21 | Sponsor Protocol Number: LOC-2013 | Start Date*: 2013-06-18 |
| Sponsor Name:Harry Scheinin | ||
| Full Title: The Neural Mechanisms of Anesthesia and Human Consciousness | ||
| Medical condition: No medical condition or disease involved. The study subjects are healthy volunteers. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-004982-10 | Sponsor Protocol Number: LOC-2016 | Start Date*: 2015-12-15 |
| Sponsor Name:Harry Scheinin | ||
| Full Title: The Neural Mechanisms of Anesthesia and Human Consciousness (Part 6) | ||
| Medical condition: No medical condition or disease involved. The study subjects are healthy volunteers. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-001668-21 | Sponsor Protocol Number: FDE_2014_25 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Fondation Ophtalomologique A. de Rothschild | |||||||||||||
| Full Title: Addition of neuromuscular-blocking agents during induction in infants: potential interest in reducing hypoxia episodes | |||||||||||||
| Medical condition: Chirurgie programmée sous anesthésie générale avec intubation orotrachéale, avec induction inhalatoire prévue | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-003279-28 | Sponsor Protocol Number: LT2380-PII-11/07 | Start Date*: 2008-07-24 | |||||||||||||||||||||
| Sponsor Name:Laboratoires Théa | |||||||||||||||||||||||
| Full Title: Efficacy and safety assessment of intracameral T2380 (Fixed combination of lidocaïne, phenylephrine and tropicamide) for anaesthesia and mydriasis in phacoemulsification cataract surgery | |||||||||||||||||||||||
| Medical condition: The aim of the development was to develop a combination of active substances enabling to obtain at the same time a mydriasis and an anaesthesia during cataract surgery. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: FR (Ongoing) ES (Ongoing) BE (Completed) PT (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2006-001761-42 | Sponsor Protocol Number: 0869-131 | Start Date*: 2006-06-12 | |||||||||||
| Sponsor Name:Merck & Co., Inc | |||||||||||||
| Full Title: A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of Aprepitant for the ... | |||||||||||||
| Medical condition: Postoperative Nausea and Vomiting | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: LT (Prematurely Ended) AT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-001738-33 | Sponsor Protocol Number: I14032 | Start Date*: 2015-09-24 | |||||||||||
| Sponsor Name:CHU de LIMOGES | |||||||||||||
| Full Title: Programmed Intermittent Epidural Bolus versus Continuous Epidural Infusion for third trimester voluntary termination of pregnancy analgesia : a randomized study. | |||||||||||||
| Medical condition: Termination Pregancy | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-003231-71 | Sponsor Protocol Number: NOT APPLICABLE | Start Date*: 2006-12-08 | |||||||||||
| Sponsor Name:Dept of Anaesthesia, University College Hospital, Galway | |||||||||||||
| Full Title: Determination of the efficacy of the Transversus Abdominis Plane Block in the management of postoperative pain in children post open abdominal surgery. | |||||||||||||
| Medical condition: Postoperative pain in children post open abdominal surgery | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: IE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-000188-33 | Sponsor Protocol Number: MK-8616-146 | Start Date*: 2017-10-27 | |||||||||||
| Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
| Full Title: A Phase 4 Randomized, Active-Comparator Controlled Trial to Study the Efficacy and Safety of Sugammadex (MK-8616) for the Reversal of Neuromuscular Blockade Induced by Either Rocuronium Bromide or ... | |||||||||||||
| Medical condition: Reversal of neuromuscular blockade | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) BE (Completed) AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-004679-37 | Sponsor Protocol Number: GECOP-MMC | Start Date*: Information not available in EudraCT |
| Sponsor Name:Hospital Universitario de Fuenlabrada | ||
| Full Title: Phase IV multicentric clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with Mytomicin-C after complete surgical cytoreduction in patients with Colon Canc... | ||
| Medical condition: Surgical resection combined with intraperitoneal chemotherapy (CT) is the best treatment for selected patients with Peritoneal Metastases from colon cancer. However, the real role of intraperitonea... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.